search button
Open Access

miR‑1207‑5p regulates the sensitivity of triple‑negative breast cancer cells to Taxol treatment via the suppression of LZTS1 expression

  • Authors:
    • Xiaoke Hou
    • Zhaofeng Niu
    • Leilei Liu
    • Qiang Guo
    • Haiyang Li
    • Xiaojun Yang
    • Xia Zhang

  • View Affiliations

  • Published online on: November 12, 2018     https://doi.org/10.3892/ol.2018.9687
  • Pages: 990-998

  • Copyright: © Hou et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Taxol‑based chemotherapy is a conventional therapeutic approach for the treatment of triple‑negative breast cancer (TNBC). However, the insensitivity of TNBC cells to Taxol greatly limits the anticancer effect of the drug and leads to patient mortality. The present study first evaluated the expression levels of microRNA (miR)‑1207‑5p in human normal breast epithelial MCF‑10A cells and TNBC cell lines (MDA‑MB‑231, MDA‑MB‑436 and MDA‑MB‑453). The results revealed that the highest miR‑1207‑5p level was in MDA‑MB‑231, which suggested an oncogenic role of miR‑1207‑5p in TNBC. Therefore, MDA‑MB‑231 served as the present study's research model in subsequent experiments. The mRNAs that functioned as tumor suppressor factors for miR‑1207‑5p were then determined. Leucine zipper tumor suppressor gene 1 (LZTS1), which was predicted by TargetScan 6.2 and was supported by the results of a dual luciferase assay, was identified as a target of miR‑1207‑5p. AntagomiR‑1207‑5p increased LZTS1 mRNA and protein expressions, enhanced cell growth arrest and cell apoptosis induced by Taxol in MDA‑MB‑231 cells. Additionally, it was observed that, when compared with Taxol treatment, the combination of Taxol and antagomiR‑1207‑5p induced a sharp decrease in B‑cell lymphoma 2 (Bcl‑2) and phosphorylated‑protein kinase B expression accompanied by an increase in the Bcl‑2‑associated X protein expression. Finally, miR‑1207‑5p expression was significantly increased, while LZTS1 expression was significantly decreased, in TNBC tissues when compared with normal adjacent tissues, and there was a negative correlation between miR‑1207‑5p and LZTS1 expression. In addition, there was a notable elevation in the expression of miR‑1207‑5p and a reduction in the expression of LZTS1 in the Taxol non‑responsive TNBC tissues when compared with the Taxol‑responsive TNBC tissues. The results of the present study suggested that miR‑1207‑5p may be a promising predictor of sensitivity towards Taxol in TNBC.
View Figures
View References

Related Articles

Journal Cover

January-2019
Volume 17 Issue 1

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

  • Journal Metrics
  • Impact Factor: 2.9
  • Ranked Oncology
    (total number of cites)
  • CiteScore: 6.3
  • CiteScore Rank: Q2: #119/366 Oncology
  • Source Normalized Impact per Paper (SNIP): 0.725
  • SCImago Journal Rank (SJR): 0.639
International Symposium on Molecular Medicine Conference Banner
The Cancer Story
World Congress on Advances in Oncology and International Symposium on Molecular Medicine Conference Banner
World Academy Of Sciences Banner
Heyday Road Banner

0

Copy and paste a formatted citation
x
Spandidos Publications style
Hou X, Niu Z, Liu L, Guo Q, Li H, Yang X and Zhang X: miR‑1207‑5p regulates the sensitivity of triple‑negative breast cancer cells to Taxol treatment via the suppression of LZTS1 expression. Oncol Lett 17: 990-998, 2019
APA
Hou, X., Niu, Z., Liu, L., Guo, Q., Li, H., Yang, X., & Zhang, X. (2019). miR‑1207‑5p regulates the sensitivity of triple‑negative breast cancer cells to Taxol treatment via the suppression of LZTS1 expression. Oncology Letters, 17, 990-998. https://doi.org/10.3892/ol.2018.9687
MLA
Hou, X., Niu, Z., Liu, L., Guo, Q., Li, H., Yang, X., Zhang, X."miR‑1207‑5p regulates the sensitivity of triple‑negative breast cancer cells to Taxol treatment via the suppression of LZTS1 expression". Oncology Letters 17.1 (2019): 990-998.
Chicago
Hou, X., Niu, Z., Liu, L., Guo, Q., Li, H., Yang, X., Zhang, X."miR‑1207‑5p regulates the sensitivity of triple‑negative breast cancer cells to Taxol treatment via the suppression of LZTS1 expression". Oncology Letters 17, no. 1 (2019): 990-998. https://doi.org/10.3892/ol.2018.9687